Community Health Q4 revenue slightly misses analyst expectations

Reuters
Feb 19
Community Health Q4 revenue slightly misses analyst expectations

Overview

  • Healthcare provider's Q4 revenue slightly missed analyst expectations

  • Adjusted EBITDA for Q4 slightly missed analyst estimates

  • Company redeemed $223 mln of senior secured notes, improving financial position

Result Drivers

  • ADMISSIONS DECLINE - Co reported a 6.6% decrease in admissions and a 6.8% decrease in adjusted admissions, impacting net operating revenues

  • BUSINESS SALES - Net income increased due to a net gain on the sale of businesses in 2025 compared to a net loss in 2024

  • REIMBURSEMENT RATES - Increased reimbursement rates partially offset the decrease in Adjusted EBITDA

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Slight Miss*

$3.11 bln

$3.14 bln (7 Analysts)

Q4 Adjusted EBITDA

Slight Miss*

$395 mln

$395.69 mln (8 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 6 "hold" and 2 "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy."

  • Wall Street's median 12-month price target for Community Health Systems Inc is $3.80, about 10.5% above its February 17 closing price of $3.44

Press Release: ID:nBw6B79Cpa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10